WMHIGH SIGNALOPERATIONAL10-K

WM appears to have completed a transformative acquisition of Stericycle, dramatically expanding revenue by 290% while simultaneously removing key risk factor disclosures from their filing.

The massive revenue increase combined with new healthcare solutions segment language strongly suggests the Stericycle acquisition has closed, fundamentally changing WM's business profile from primarily waste management to a diversified waste and healthcare services company. The removal of risk factor language, including specific risks about the Stericycle acquisition and operational safety concerns, is concerning as it reduces transparency precisely when investors need more disclosure about this transformed entity.

Comparing 2026-02-09 vs 2025-02-19View on EDGAR →
FINANCIAL ANALYSIS

The financials reflect a dramatic business transformation with revenue exploding 290% to $14.5B while operating cash flow grew a modest 12% to $6.0B, suggesting the acquired business may be less cash-generative than WM's core operations. Management significantly reduced share buybacks by 80% to $262M while increasing capex 38% to $2.8B, indicating a shift toward reinvestment over shareholder returns. The 51% decline in cash to just $201M combined with the equity increase to $10.0B suggests this was likely a stock-heavy acquisition that has left the company with reduced financial flexibility.

FINANCIAL STATEMENT CHANGES
Revenue
P&L
+289.8%
$3.7B→$14.5B

Strong top-line growth of 289.8% — accelerating demand or successful expansion into new markets.

Share Buybacks
Cash Flow
-79.9%
$1.3B→$262.0M

Buyback activity reduced 79.9% — capital being redeployed elsewhere or cash conservation underway.

Cash & Equivalents
Balance Sheet
-51.4%
$414.0M→$201.0M

Cash declined 51.4% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Capital Expenditure
Cash Flow
+37.8%
$2.0B→$2.8B

Capital expenditure jumped 37.8% — major investment cycle underway; assess returns on deployment.

Stockholders Equity
Balance Sheet
+21.1%
$8.3B→$10.0B

Equity base grew 21.1% — retained earnings accumulation or equity issuance strengthening the balance sheet.

SG&A Expense
P&L
+20.2%
$2.3B→$2.7B

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

Operating Cash Flow
Cash Flow
+12.1%
$5.4B→$6.0B

Operating cash flow grew 12.1% — strong conversion of earnings to cash, healthy business fundamentals.

Current Liabilities
Balance Sheet
-11.7%
$6.3B→$5.5B

Current liabilities reduced — improved short-term financial position and working capital health.

LANGUAGE CHANGES
NEW — 2026-02-09
PRIOR — 2025-02-19
ADDED
and Canada that produce renewable electricity and renewable natural gas ( RNG ), which is a significant source of fuel that we allocate to our natural gas fleet.
( Stericycle ), our Healthcare Solutions segment provides regulated waste and compliance services ( RWCS ) and secure information destruction ( SID ) services in the U.S., Canada and Western Europe that protect people and brands, promote health and well-being and safeguard the environment.
Additionally, through our Recycling Processing and Sales segment, we are a leading recycler in the U.S.
During 2025, our largest customer represented less than 5% of annual revenues.
We have enabled a people-first, technology-led focus to drive our mission to maximize resource value, while minimizing environmental impact, and sustainability and environmental stewardship is embedded in all that we do.
+7 more — sign up free →
REMOVED
Risk Factors Summary Our business is subject to numerous risks and uncertainties, including those described in Part I, Item 1A.
These risks include the following: Strategy and Operational Risks If we fail to implement our business strategy, our financial performance and our growth could be materially and adversely affected.
We may not realize the strategic benefits and cost synergies anticipated from the Stericycle acquisition.
Our operations must comply with extensive existing regulations, and changes in regulations, including with respect to emerging contaminants, such as PFAS (as defined below), and extended producer responsibility, can restrict or alter our operations, increase our operating costs, increase our tax liabilities, reduce revenues, or require us to make additional capital expenditures.
Our business is subject to operational and safety risks, including the risk of injury to employees and others.
+7 more — sign up free →
MORE OPERATIONAL SIGNALS
HOFTHIGHHOFT completed a major divestiture of its Pulaski and Samuel Lawrence furniture ...
2026-04-17
CTRNHIGHCTRN underwent a dramatic operational turnaround with a complete repositioning f...
2026-04-15
ORBSHIGHORBS has undergone a complete business transformation from packaging and e-comme...
2026-04-15
BRFHHIGHBRFH completed a transformative acquisition of Arps Dairy in October 2025, drama...
2026-04-15
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →